Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Clinical Trial ID NCT02445976

PubWeight™ 3.10‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02445976

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. Int J Biol Sci 2016 0.81
2 Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer. Curr Urol Rep 2016 0.77
3 Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer. Curr Opin Endocrinol Diabetes Obes 2016 0.76
4 Precision medicine for advanced prostate cancer. Curr Opin Urol 2016 0.76
Next 100